Ty-jour t1 - 癌症患者临床特征和3个月的临床特征与临床疑似和证实的肺栓塞JF - 欧洲呼吸杂志Jo - Eur Respir J Do - 10.1183 / 13993003.02723-2020 vl -58是 - 1 sp - 2002723 Au - Peris，Marisa Au - López-nuñez，Juan J. Au - Maestre，Ana Au - Jimenez，David Au - Muriel，Alfonso Au - Bikdeli，Behnood Au - Weinberg，IDO Au - Weinberg，IDO Au - Ay，Cihan Au - Mazzolai，Lucia Au - Lorenzo，Alicia Au - Monreal，Manuel Au - Riete Investigator Y1 - 2021/07/01 UR - //www.qdcxjkg.com/content/58/1/2002723.abstract n2- 背景技术目前的指南表明，与临床疑似和确认的PE类似的人同样地治疗患有肺栓塞（PE）的癌症患者。但是，这些演示文稿的自然历史尚未彻底进行比较。我们使用来自RIETE（REVERTM Informatizodo De EnvermedadTromboembólica）的数据的数据，以比较活性癌症和偶然的PE与临床疑似的患者的3个月结果并确认PE。主要结果是90天的全导致死亡率。二次结果是体育病人有关的死亡率，症状性体育复发和重大出血。从2012年7月至2019年1月，946例患有临床疑似和证实PE的946例患有临床疑似和证实PE的癌症患者。大多数患者（95％对90％）接受了低分子量的肝素治疗。在前90天，598名患者死亡，其中42例来自PE。 Patients with incidental PE had a lower all-cause mortality rate than those with suspected and confirmed PE (11% versus 22%; OR 0.43, 95% CI 0.34–0.54). Results were consistent for PE-related mortality (0.3% versus 1.7%; OR 0.18, 95% CI 0.06–0.59). Multivariable analysis confirmed that patients with incidental PE were at lower risk of death (adjusted OR 0.43, 95% CI 0.34–0.56). Overall, 29 (0.9%) patients developed symptomatic PE recurrences, and 122 (3.8%) had major bleeding. There were no significant differences in PE recurrences (OR 0.62, 95% CI 0.25–1.54) or major bleeding (OR 0.78, 95% CI 0.51–1.18).Conclusions Cancer patients with incidental PE had a lower mortality rate than those with clinically suspected and confirmed PE. Further studies are required to validate these findings, and to explore optimal management strategies in these patients.In cancer patients with incidental pulmonary embolism the risk of venous thromboembolism recurrences or major bleeding are similar, with a lower mortality https://bit.ly/36AVqSy ER -